Tyra Biosciences Inc.
Organization details
- Legal name
- Tyra Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Carlsbad
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TYRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001863127
- EIN
- 83-1476348
Board of directors
-
Adele M. Gulfo · DirectorSince 2025
-
Gilla Kaplan · DirectorSince 2023
- Since 2026
-
Isan Chen · DirectorSince 2023
- Since 2023
-
Nina S. Kjellson · DirectorSince 2023
- Since 2023
- Since 2023
-
Rehan Verjee · DirectorSince 2023
-
Robert J. More · DirectorSince 2023
-
Siddarth Subramony · DirectorSince 2023
-
Stephen Michael Rothenberg · DirectorSince 2024
-
Susan Moran · DirectorSince 2024
-
Todd Harris · Director · President and CEOSince 2023
Chief executives
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.7%
-
98.9%
Board connections
9 of this board's directors also sit on 32 other boards. 31 are in the same sector.
-
Bicara Therapeutics Inc. Same sectorvia Jake Simson, Peter Kolchinsky and Rajeev M. Shah
-
Jade Biosciences Inc. Same sectorvia Habib J. Dable, Peter Kolchinsky and Rajeev M. Shah
-
Janux Therapeutics Inc. Same sectorvia Jake Simson, Peter Kolchinsky and Rajeev M. Shah
-
Parabilis Medicines Inc. Same sectorvia Jake Simson, Peter Kolchinsky and Rajeev M. Shah
-
PepGen Inc. Same sectorvia Habib J. Dable, Peter Kolchinsky and Rajeev M. Shah
-
Septerna Inc. Same sectorvia Jake Simson, Peter Kolchinsky and Rajeev M. Shah
-
SpyGlass Pharma Inc. Same sectorvia Habib J. Dable, Peter Kolchinsky and Rajeev M. Shah
-
ARS Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acrivon Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acumen Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Artiva Biotherapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bambusa Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Black Diamond Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Climb Bio Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Evommune Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Freenome Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Hemab Therapeutics Holdings Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
LENZ Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Mineralys Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Nkarta Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Sionna Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Solid Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Vor Biopharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Wave Life Sciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Werewolf Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Avalo Therapeutics Inc. Same sectorvia Gilla Kaplan
-
Crescent Biopharma Inc. Same sectorvia Susan Moran
-
Eloxx Pharmaceuticals Inc. Same sectorvia Nina S. Kjellson
- via Adele M. Gulfo
-
NewAmsterdam Pharma Company N.V. Same sectorvia Adele M. Gulfo
-
Relay Therapeutics Inc. Same sectorvia Habib J. Dable
-
Vir Biotechnology Inc. Same sectorvia Robert J. More
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $20,002
- 1 purchase by 1 insider
- Sold, last 12 months
- $10,589,028
- 14 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Fuhrman Alan Officer (Chief Financial Officer) | Grant or award | +951 | $9.13 | $8,683 |
| Sep 15, 2026 | Todd Harris Director, Officer (President and CEO) | Grant or award | +864 | $9.13 | $7,888 |
| Sep 15, 2026 | Rueb Yuliya Officer (Vice President, Finance (PAO)) | Grant or award | +2,925 | $9.13 | $26,705 |
| Sep 9, 2026 | Rehan Verjee Director | Open-market purchase | +972 | $20.58 | $20,002 |
| May 5, 2026 | Warner Douglas J Officer (Chief Medical Officer) | Grant or award | +25,000 | — | — |
| May 5, 2026 | Fuhrman Alan Officer (Chief Financial Officer) | Grant or award | +20,000 | — | — |
| May 5, 2026 | Todd Harris Director, Officer (President and CEO) | Grant or award | +79,000 | — | — |
| May 5, 2026 | Ashar Bhavesh Officer (Chief Operating Officer) | Grant or award | +15,013 | — | — |
| May 5, 2026 | Rueb Yuliya Officer (Vice President, Finance (PAO)) | Grant or award | +8,333 | — | — |
| Mar 26, 2026 | Gilla Kaplan Director | Option exercise | −53,172 | $2.25 | $119,637 |
| Mar 26, 2026 | Gilla Kaplan Director | Sold back to the company | −53,172 | $37.75 | $2,007,243 |
| Mar 25, 2026 | Gilla Kaplan Director | Option exercise | +14,295 | $2.25 | $32,164 |
| Mar 25, 2026 | Gilla Kaplan Director | Open-market sale | −14,295 | $36.97 | $528,486 |
| Mar 13, 2026 | Fuhrman Alan Officer (Chief Financial Officer) | Grant or award | +1,376 | $9.13 | $12,563 |
| Mar 13, 2026 | Todd Harris Director, Officer (President and CEO) | Grant or award | +1,463 | $9.13 | $13,357 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Tyra Biosciences Inc.
Who is the CEO of Tyra Biosciences Inc.?
Todd Harris is Tyra Biosciences Inc.'s Chief Executive Officer.
How many directors are on Tyra Biosciences Inc.'s board?
Tyra Biosciences Inc.'s board has 14 directors: Adele M. Gulfo, Gilla Kaplan, Habib J. Dable, Isan Chen, Jake Simson, Nina S. Kjellson, Peter Kolchinsky, Rajeev M. Shah, Rehan Verjee, Robert J. More and 4 others.
Are Tyra Biosciences Inc. insiders buying or selling shares?
Over the last 12 months, Tyra Biosciences Inc. insiders bought $20,002 of shares in 1 purchase and sold $10.6 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tyra-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.